DE NOVO THIRD PARTY HLA ANTIBODIES SYNERGIZE WITH DE NOVO DONOR SPECIFIC HLA ANTIBODIES TO NEGATIVELY IMPACT LUNG ALLOGRAFT OUTCOME

被引：0
|
作者：
Zhang, Aiwen [1 ]
Good, Derek J. [1 ]
Thomas, Dawn M. [1 ]
Walendzik, Allison [1 ]
Cagahastian, Van [1 ]
Allen, Jeffrey [1 ]
McMichael, John [1 ]
McCurry, Kenneth [2 ]
Budev, Marie [2 ]
Gebel, Howard M. [3 ]
Bray, Robert A. [3 ]
机构：
[1] Cleveland Clin, Allogen Labs, Cleveland, OH 44106 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] Emory Univ Hosp, 1364 Clifton Rd NE, Atlanta, GA 30322 USA
来源：
HUMAN IMMUNOLOGY | 2019年 / 80卷
关键词：
D O I：
10.1016/j.humimm.2019.07.027
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
OR25
引用
收藏
页码：32 / 33
页数：2
相关论文
共 50 条
  • [31] Are De Novo DQ Donor-Specific Antibodies the Key to Chronic Lung Allograft Dysfunction?
    Shenoy, Kartik V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 194 (05) : 534 - 535
  • [32] De Novo DQ Donor-Specific Antibodies Are Associated With Chronic Lung Allograft Dysfunction
    Tikkanen, J. M.
    Singer, L. G.
    Azad, S.
    Binnie, M.
    Chaparro, C.
    Chow, C.
    Cypel, M.
    dePerrot, M.
    Pierre, A.
    Yasufuku, K.
    Waddell, T. K.
    Keshavjee, S.
    Tinckam, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04) : S98 - S99
  • [33] PERSISTENCE OF DE NOVO DONORSPECIFIC HLA-ANTIBODIES SEEMS TO INCREASE THE RISK OF LUNG ALLOGRAFT DYSFUNCTION
    Schmitzer, Magdalena
    Winter, Hauke
    Kneidinger, Nikolaus
    Dick, Andrea
    Neurohr, Claus
    Kauke, Teresa
    HLA, 2016, 87 (04) : 246 - 246
  • [34] THE IMPACT OF DE-NOVO DONOR SPECIFIC AND - NONSPECIFIC ANTIBODIES ON OUTCOME AFTER HTX
    Barten, M. J.
    Konertz, J.
    Wachendorfer, L.
    Bernhardt, A.
    Reichenspurner, H.
    TRANSPLANT INTERNATIONAL, 2021, 34 : 29 - 30
  • [35] Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival
    Guidicelli, Gwendaline
    Guerville, Florent
    Lepreux, Sebastien
    Wiebe, Chris
    Thaunat, Olivier
    Dubois, Valerie
    Visentin, Jonathan
    Bachelet, Thomas
    Morelon, Emmanuel
    Nickerson, Peter
    Merville, Pierre
    Taupin, Jean-Luc
    Couzi, Lionel
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (02): : 615 - 625
  • [36] The Impact of Repeat HLA Mismatches on the Development of De Novo Donor Specific HLA Antbodies (DSA) in Lung ReTransplants
    Askar, M.
    Reville, P.
    Daghstani, J.
    Klingman, L.
    McCurry, K.
    Budev, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04) : S172 - S172
  • [37] Preemptive Treatment of De Novo Donor Specific Anti-HLA Antibodies With IVIG Monotherapy after Lung Transplantation
    McDermott, Jennifer K.
    Castaneda, Skye J.
    Mietz, Sarah M.
    Lawson, Cameron K.
    Gerlach, John A.
    Hadley, Ryan J.
    Sathiyamoorthy, Gayathri
    Krishnan, Sheila
    Murphy, Edward T.
    Girgis, Reda E.
    TRANSPLANT INTERNATIONAL, 2024, 37
  • [38] DE NOVO DONOR-SPECIFIC ANTIBODIES (DSA) AND THEIR IMPACT ON OUTCOMES IN LUNG TRANSPLANTATION
    Enrica, Pacquola
    Elisa, Trovato Salinaro
    Daniela, Zanotto
    Fabio, Agusson
    Laura, del Giudice
    Monica, Loy
    Arianna, Veronesi
    Giustina, De Silvestro
    HLA, 2019, 93 (05) : 309 - 310
  • [39] Impact of de novo donor-specific HLA antibodies on pediatric kidney transplant prognosis in patients with acute declined or stable allograft function
    Fylaktou, Asimina
    Karava, Vasiliki
    Vittoraki, Angeliki
    Zampetoglou, Argyroula
    Papachristou, Marianthi
    Antoniadis, Nikolaos
    Iniotaki, Aliki
    Mitsioni, Andromach
    Printza, Nikoleta
    PEDIATRIC TRANSPLANTATION, 2022, 26 (03)
  • [40] De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation
    Safavi, Shahideh
    Robinson, Derek R.
    Soresi, Simona
    Carby, Martin
    Smith, John D.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (12) : 1273 - 1281
12345